The Doctor's Channel has partnered with ReelDX to bring you a new video case each week. Take the challenge to see if you can you diagnose this patient's…
Craig A. Dionne, PhD, CEO of GenSpera, describes some of the drawbacks associated with common cancer treatments. Many types of drug therapies, like antiangiogenics and immunotherapies, may only…
Mipsagargin (G-202), a new prodrug developed by GenSpera, has a unique mechanism of action that allows it to kill cancer cells without damaging surrounding tissues. Derived from thapsigargin,…
Engineers have developed 3D-printable miniature "fish" that may be capable of propelling themselves through blood vessels and delivering drugs to specific cells.
The unique pharmacokinetic properties of TXA-709 may allow it to effectively treat staphylococcus aureus infections, including MRSA, while reducing the possibility of patients developing a resistance to the…